daypro

Generic: oxaprozin

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name daypro
Generic Name oxaprozin
Labeler pfizer laboratories div pfizer inc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

oxaprozin 600 mg/1

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0025-1381
Product ID 0025-1381_30a6488d-0471-4a93-8426-afd35a105254
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018841
Marketing Start 1992-10-29
Marketing End 2026-04-30

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00251381
Hyphenated Format 0025-1381

Supplemental Identifiers

RxCUI
207243 312132
UPC
0300251381317
UNII
MHJ80W9LRB
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name daypro (source: ndc)
Generic Name oxaprozin (source: ndc)
Application Number NDA018841 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (0025-1381-31)
source: ndc

Packages (1)

Ingredients (1)

oxaprozin (600 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "30a6488d-0471-4a93-8426-afd35a105254", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0300251381317"], "unii": ["MHJ80W9LRB"], "rxcui": ["207243", "312132"], "spl_set_id": ["ea1de47e-3101-4414-817c-0a098af8988c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0025-1381-31)", "package_ndc": "0025-1381-31", "marketing_end_date": "20260430", "marketing_start_date": "19921029"}], "brand_name": "Daypro", "product_id": "0025-1381_30a6488d-0471-4a93-8426-afd35a105254", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "0025-1381", "generic_name": "oxaprozin", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daypro", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "NDA018841", "marketing_category": "NDA", "marketing_end_date": "20260430", "marketing_start_date": "19921029"}